Global Hemostatic Powders and Hemostatic Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 130
Published Date: 11 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Hemostatic Powders and Hemostatic Agents market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Hemostatic powders and hemostatic agents are medical products used to control bleeding or promote hemostasis (the process of stopping bleeding) in various clinical settings. These products are designed to aid in the management of bleeding in situations where conventional methods such as pressure, sutures, or cauterization may be insufficient or impractical.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Hemostatic Powders and Hemostatic Agents industry chain, the market status of Home (Microfibrous Collagen, Chitosan), Clinic (Microfibrous Collagen, Chitosan), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hemostatic Powders and Hemostatic Agents.
Regionally, the report analyzes the Hemostatic Powders and Hemostatic Agents markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hemostatic Powders and Hemostatic Agents market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hemostatic Powders and Hemostatic Agents market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hemostatic Powders and Hemostatic Agents industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Microfibrous Collagen, Chitosan).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hemostatic Powders and Hemostatic Agents market.
Regional Analysis: The report involves examining the Hemostatic Powders and Hemostatic Agents market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hemostatic Powders and Hemostatic Agents market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hemostatic Powders and Hemostatic Agents:
Company Analysis: Report covers individual Hemostatic Powders and Hemostatic Agents players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hemostatic Powders and Hemostatic Agents This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Home, Clinic).
Technology Analysis: Report covers specific technologies relevant to Hemostatic Powders and Hemostatic Agents. It assesses the current state, advancements, and potential future developments in Hemostatic Powders and Hemostatic Agents areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hemostatic Powders and Hemostatic Agents market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hemostatic Powders and Hemostatic Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Microfibrous Collagen
Chitosan
Market segment by Application
Home
Clinic
Hospital
Market segment by players, this report covers
BD
Medline Industries
Baxter
Pfizer
Zimmer Biomet
McKesson
Integra Life Sciences
Medtronic
CryoLife
CSL Behring
Ethicon
B Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex
Novartis
Anika Therapeutics
Advanced Medical Solutions
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hemostatic Powders and Hemostatic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hemostatic Powders and Hemostatic Agents, with revenue, gross margin and global market share of Hemostatic Powders and Hemostatic Agents from 2019 to 2024.
Chapter 3, the Hemostatic Powders and Hemostatic Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hemostatic Powders and Hemostatic Agents market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hemostatic Powders and Hemostatic Agents.
Chapter 13, to describe Hemostatic Powders and Hemostatic Agents research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Hemostatic Powders and Hemostatic Agents
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hemostatic Powders and Hemostatic Agents by Type
1.3.1 Overview: Global Hemostatic Powders and Hemostatic Agents Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Type in 2023
1.3.3 Microfibrous Collagen
1.3.4 Chitosan
1.4 Global Hemostatic Powders and Hemostatic Agents Market by Application
1.4.1 Overview: Global Hemostatic Powders and Hemostatic Agents Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Home
1.4.3 Clinic
1.4.4 Hospital
1.5 Global Hemostatic Powders and Hemostatic Agents Market Size & Forecast
1.6 Global Hemostatic Powders and Hemostatic Agents Market Size and Forecast by Region
1.6.1 Global Hemostatic Powders and Hemostatic Agents Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hemostatic Powders and Hemostatic Agents Market Size by Region, (2019-2030)
1.6.3 North America Hemostatic Powders and Hemostatic Agents Market Size and Prospect (2019-2030)
1.6.4 Europe Hemostatic Powders and Hemostatic Agents Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size and Prospect (2019-2030)
1.6.6 South America Hemostatic Powders and Hemostatic Agents Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Hemostatic Powders and Hemostatic Agents Market Size and Prospect (2019-2030)
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Hemostatic Powders and Hemostatic Agents Product and Solutions
2.1.4 BD Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments and Future Plans
2.2 Medline Industries
2.2.1 Medline Industries Details
2.2.2 Medline Industries Major Business
2.2.3 Medline Industries Hemostatic Powders and Hemostatic Agents Product and Solutions
2.2.4 Medline Industries Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medline Industries Recent Developments and Future Plans
2.3 Baxter
2.3.1 Baxter Details
2.3.2 Baxter Major Business
2.3.3 Baxter Hemostatic Powders and Hemostatic Agents Product and Solutions
2.3.4 Baxter Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Baxter Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Hemostatic Powders and Hemostatic Agents Product and Solutions
2.4.4 Pfizer Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Zimmer Biomet
2.5.1 Zimmer Biomet Details
2.5.2 Zimmer Biomet Major Business
2.5.3 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Product and Solutions
2.5.4 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Zimmer Biomet Recent Developments and Future Plans
2.6 McKesson
2.6.1 McKesson Details
2.6.2 McKesson Major Business
2.6.3 McKesson Hemostatic Powders and Hemostatic Agents Product and Solutions
2.6.4 McKesson Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 McKesson Recent Developments and Future Plans
2.7 Integra Life Sciences
2.7.1 Integra Life Sciences Details
2.7.2 Integra Life Sciences Major Business
2.7.3 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Product and Solutions
2.7.4 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Integra Life Sciences Recent Developments and Future Plans
2.8 Medtronic
2.8.1 Medtronic Details
2.8.2 Medtronic Major Business
2.8.3 Medtronic Hemostatic Powders and Hemostatic Agents Product and Solutions
2.8.4 Medtronic Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Medtronic Recent Developments and Future Plans
2.9 CryoLife
2.9.1 CryoLife Details
2.9.2 CryoLife Major Business
2.9.3 CryoLife Hemostatic Powders and Hemostatic Agents Product and Solutions
2.9.4 CryoLife Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 CryoLife Recent Developments and Future Plans
2.10 CSL Behring
2.10.1 CSL Behring Details
2.10.2 CSL Behring Major Business
2.10.3 CSL Behring Hemostatic Powders and Hemostatic Agents Product and Solutions
2.10.4 CSL Behring Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CSL Behring Recent Developments and Future Plans
2.11 Ethicon
2.11.1 Ethicon Details
2.11.2 Ethicon Major Business
2.11.3 Ethicon Hemostatic Powders and Hemostatic Agents Product and Solutions
2.11.4 Ethicon Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ethicon Recent Developments and Future Plans
2.12 B Braun Melsungen
2.12.1 B Braun Melsungen Details
2.12.2 B Braun Melsungen Major Business
2.12.3 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Product and Solutions
2.12.4 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 B Braun Melsungen Recent Developments and Future Plans
2.13 Gelita Medical
2.13.1 Gelita Medical Details
2.13.2 Gelita Medical Major Business
2.13.3 Gelita Medical Hemostatic Powders and Hemostatic Agents Product and Solutions
2.13.4 Gelita Medical Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Gelita Medical Recent Developments and Future Plans
2.14 Smith & Nephew
2.14.1 Smith & Nephew Details
2.14.2 Smith & Nephew Major Business
2.14.3 Smith & Nephew Hemostatic Powders and Hemostatic Agents Product and Solutions
2.14.4 Smith & Nephew Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Smith & Nephew Recent Developments and Future Plans
2.15 Teleflex
2.15.1 Teleflex Details
2.15.2 Teleflex Major Business
2.15.3 Teleflex Hemostatic Powders and Hemostatic Agents Product and Solutions
2.15.4 Teleflex Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Teleflex Recent Developments and Future Plans
2.16 Novartis
2.16.1 Novartis Details
2.16.2 Novartis Major Business
2.16.3 Novartis Hemostatic Powders and Hemostatic Agents Product and Solutions
2.16.4 Novartis Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Novartis Recent Developments and Future Plans
2.17 Anika Therapeutics
2.17.1 Anika Therapeutics Details
2.17.2 Anika Therapeutics Major Business
2.17.3 Anika Therapeutics Hemostatic Powders and Hemostatic Agents Product and Solutions
2.17.4 Anika Therapeutics Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Anika Therapeutics Recent Developments and Future Plans
2.18 Advanced Medical Solutions
2.18.1 Advanced Medical Solutions Details
2.18.2 Advanced Medical Solutions Major Business
2.18.3 Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Product and Solutions
2.18.4 Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Advanced Medical Solutions Recent Developments and Future Plans
3.1 Global Hemostatic Powders and Hemostatic Agents Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hemostatic Powders and Hemostatic Agents by Company Revenue
3.2.2 Top 3 Hemostatic Powders and Hemostatic Agents Players Market Share in 2023
3.2.3 Top 6 Hemostatic Powders and Hemostatic Agents Players Market Share in 2023
3.3 Hemostatic Powders and Hemostatic Agents Market: Overall Company Footprint Analysis
3.3.1 Hemostatic Powders and Hemostatic Agents Market: Region Footprint
3.3.2 Hemostatic Powders and Hemostatic Agents Market: Company Product Type Footprint
3.3.3 Hemostatic Powders and Hemostatic Agents Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Hemostatic Powders and Hemostatic Agents Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hemostatic Powders and Hemostatic Agents Market Forecast by Type (2025-2030)
5.1 Global Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Application (2019-2024)
5.2 Global Hemostatic Powders and Hemostatic Agents Market Forecast by Application (2025-2030)
6.1 North America Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2030)
6.2 North America Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2030)
6.3 North America Hemostatic Powders and Hemostatic Agents Market Size by Country
6.3.1 North America Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2030)
6.3.2 United States Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
6.3.3 Canada Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
6.3.4 Mexico Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
7.1 Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2030)
7.2 Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2030)
7.3 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country
7.3.1 Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2030)
7.3.2 Germany Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
7.3.3 France Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
7.3.5 Russia Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
7.3.6 Italy Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region
8.3.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Region (2019-2030)
8.3.2 China Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
8.3.3 Japan Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
8.3.4 South Korea Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
8.3.5 India Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
8.3.7 Australia Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
9.1 South America Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2030)
9.2 South America Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2030)
9.3 South America Hemostatic Powders and Hemostatic Agents Market Size by Country
9.3.1 South America Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2030)
9.3.2 Brazil Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
9.3.3 Argentina Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country
10.3.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2030)
10.3.2 Turkey Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
10.3.4 UAE Hemostatic Powders and Hemostatic Agents Market Size and Forecast (2019-2030)
11.1 Hemostatic Powders and Hemostatic Agents Market Drivers
11.2 Hemostatic Powders and Hemostatic Agents Market Restraints
11.3 Hemostatic Powders and Hemostatic Agents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Hemostatic Powders and Hemostatic Agents Industry Chain
12.2 Hemostatic Powders and Hemostatic Agents Upstream Analysis
12.3 Hemostatic Powders and Hemostatic Agents Midstream Analysis
12.4 Hemostatic Powders and Hemostatic Agents Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Hemostatic Powders and Hemostatic Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Hemostatic Powders and Hemostatic Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Hemostatic Powders and Hemostatic Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Hemostatic Powders and Hemostatic Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BD Company Information, Head Office, and Major Competitors
Table 6. BD Major Business
Table 7. BD Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 8. BD Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BD Recent Developments and Future Plans
Table 10. Medline Industries Company Information, Head Office, and Major Competitors
Table 11. Medline Industries Major Business
Table 12. Medline Industries Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 13. Medline Industries Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Medline Industries Recent Developments and Future Plans
Table 15. Baxter Company Information, Head Office, and Major Competitors
Table 16. Baxter Major Business
Table 17. Baxter Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 18. Baxter Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Baxter Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 23. Pfizer Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Zimmer Biomet Company Information, Head Office, and Major Competitors
Table 26. Zimmer Biomet Major Business
Table 27. Zimmer Biomet Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 28. Zimmer Biomet Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Zimmer Biomet Recent Developments and Future Plans
Table 30. McKesson Company Information, Head Office, and Major Competitors
Table 31. McKesson Major Business
Table 32. McKesson Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 33. McKesson Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. McKesson Recent Developments and Future Plans
Table 35. Integra Life Sciences Company Information, Head Office, and Major Competitors
Table 36. Integra Life Sciences Major Business
Table 37. Integra Life Sciences Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 38. Integra Life Sciences Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Integra Life Sciences Recent Developments and Future Plans
Table 40. Medtronic Company Information, Head Office, and Major Competitors
Table 41. Medtronic Major Business
Table 42. Medtronic Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 43. Medtronic Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Medtronic Recent Developments and Future Plans
Table 45. CryoLife Company Information, Head Office, and Major Competitors
Table 46. CryoLife Major Business
Table 47. CryoLife Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 48. CryoLife Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. CryoLife Recent Developments and Future Plans
Table 50. CSL Behring Company Information, Head Office, and Major Competitors
Table 51. CSL Behring Major Business
Table 52. CSL Behring Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 53. CSL Behring Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. CSL Behring Recent Developments and Future Plans
Table 55. Ethicon Company Information, Head Office, and Major Competitors
Table 56. Ethicon Major Business
Table 57. Ethicon Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 58. Ethicon Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Ethicon Recent Developments and Future Plans
Table 60. B Braun Melsungen Company Information, Head Office, and Major Competitors
Table 61. B Braun Melsungen Major Business
Table 62. B Braun Melsungen Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 63. B Braun Melsungen Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. B Braun Melsungen Recent Developments and Future Plans
Table 65. Gelita Medical Company Information, Head Office, and Major Competitors
Table 66. Gelita Medical Major Business
Table 67. Gelita Medical Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 68. Gelita Medical Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Gelita Medical Recent Developments and Future Plans
Table 70. Smith & Nephew Company Information, Head Office, and Major Competitors
Table 71. Smith & Nephew Major Business
Table 72. Smith & Nephew Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 73. Smith & Nephew Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Smith & Nephew Recent Developments and Future Plans
Table 75. Teleflex Company Information, Head Office, and Major Competitors
Table 76. Teleflex Major Business
Table 77. Teleflex Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 78. Teleflex Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Teleflex Recent Developments and Future Plans
Table 80. Novartis Company Information, Head Office, and Major Competitors
Table 81. Novartis Major Business
Table 82. Novartis Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 83. Novartis Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Novartis Recent Developments and Future Plans
Table 85. Anika Therapeutics Company Information, Head Office, and Major Competitors
Table 86. Anika Therapeutics Major Business
Table 87. Anika Therapeutics Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 88. Anika Therapeutics Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Anika Therapeutics Recent Developments and Future Plans
Table 90. Advanced Medical Solutions Company Information, Head Office, and Major Competitors
Table 91. Advanced Medical Solutions Major Business
Table 92. Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Product and Solutions
Table 93. Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Advanced Medical Solutions Recent Developments and Future Plans
Table 95. Global Hemostatic Powders and Hemostatic Agents Revenue (USD Million) by Players (2019-2024)
Table 96. Global Hemostatic Powders and Hemostatic Agents Revenue Share by Players (2019-2024)
Table 97. Breakdown of Hemostatic Powders and Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Hemostatic Powders and Hemostatic Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Hemostatic Powders and Hemostatic Agents Players
Table 100. Hemostatic Powders and Hemostatic Agents Market: Company Product Type Footprint
Table 101. Hemostatic Powders and Hemostatic Agents Market: Company Product Application Footprint
Table 102. Hemostatic Powders and Hemostatic Agents New Market Entrants and Barriers to Market Entry
Table 103. Hemostatic Powders and Hemostatic Agents Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Hemostatic Powders and Hemostatic Agents Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Hemostatic Powders and Hemostatic Agents Consumption Value Share by Type (2019-2024)
Table 106. Global Hemostatic Powders and Hemostatic Agents Consumption Value Forecast by Type (2025-2030)
Table 107. Global Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2024)
Table 108. Global Hemostatic Powders and Hemostatic Agents Consumption Value Forecast by Application (2025-2030)
Table 109. North America Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Hemostatic Powders and Hemostatic Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Hemostatic Powders and Hemostatic Agents Raw Material
Table 140. Key Suppliers of Hemostatic Powders and Hemostatic Agents Raw Materials
List of Figures
Figure 1. Hemostatic Powders and Hemostatic Agents Picture
Figure 2. Global Hemostatic Powders and Hemostatic Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Type in 2023
Figure 4. Microfibrous Collagen
Figure 5. Chitosan
Figure 6. Global Hemostatic Powders and Hemostatic Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Application in 2023
Figure 8. Home Picture
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Global Hemostatic Powders and Hemostatic Agents Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Hemostatic Powders and Hemostatic Agents Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Hemostatic Powders and Hemostatic Agents Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Region in 2023
Figure 16. North America Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Hemostatic Powders and Hemostatic Agents Revenue Share by Players in 2023
Figure 22. Hemostatic Powders and Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Hemostatic Powders and Hemostatic Agents Market Share in 2023
Figure 24. Global Top 6 Players Hemostatic Powders and Hemostatic Agents Market Share in 2023
Figure 25. Global Hemostatic Powders and Hemostatic Agents Consumption Value Share by Type (2019-2024)
Figure 26. Global Hemostatic Powders and Hemostatic Agents Market Share Forecast by Type (2025-2030)
Figure 27. Global Hemostatic Powders and Hemostatic Agents Consumption Value Share by Application (2019-2024)
Figure 28. Global Hemostatic Powders and Hemostatic Agents Market Share Forecast by Application (2025-2030)
Figure 29. North America Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 39. France Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Region (2019-2030)
Figure 46. China Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 49. India Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Hemostatic Powders and Hemostatic Agents Consumption Value (2019-2030) & (USD Million)
Figure 63. Hemostatic Powders and Hemostatic Agents Market Drivers
Figure 64. Hemostatic Powders and Hemostatic Agents Market Restraints
Figure 65. Hemostatic Powders and Hemostatic Agents Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Hemostatic Powders and Hemostatic Agents in 2023
Figure 68. Manufacturing Process Analysis of Hemostatic Powders and Hemostatic Agents
Figure 69. Hemostatic Powders and Hemostatic Agents Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
BD Medline Industries Baxter Pfizer Zimmer Biomet McKesson Integra Life Sciences Medtronic CryoLife CSL Behring Ethicon B Braun Melsungen Gelita Medical Smith & Nephew Teleflex Novartis Anika Therapeutics Advanced Medical Solutions
Related Reports
27 Jul 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
